期刊文献+

专用集成电路设计中的时钟偏移分析 被引量:1

Analysis of the Clock Skew in ASIC Design
下载PDF
导出
摘要 目前的专用集成电路设计中,时钟偏移对同步数字电路的影响越来越大,它也越来越受到高速电路设计者的关注,因此如何解决它给电路带来的不利影响成了设计中的重要挑战。本文分析了时钟偏移的产生机理,然后提出了怎样使用CTS在时钟树中插入不同驱动能力的缓冲器,以平衡时钟网络,最后还分析了如何利用有用的时钟偏移来改善电路的时序。 Clock skew becomes more and more important to synchronization circuits in the current ASIC design, and it is an increasing concern for high-speed circuit designers. Therefore, it has been a big challenge to reduce the defect of the clock skew in designs. In this paper, firstly the generation principle of clock skew is analyzed, and then for solving its disadvantage we propose an approach that inserts diversified buffers in clock trees, in order to balance the clock network. Finally, we analyze how to fix the timing violation of our designs by using useful clock skew
出处 《真空电子技术》 2006年第5期62-64,68,共4页 Vacuum Electronics
关键词 专用集成电路 时钟偏移 时钟树 建立时间 保持时间 时钟树综合法 ASIC Clock skew Clock tree Setup time Hold time CTS
  • 相关文献

参考文献1

二级参考文献22

  • 1Zheng Q;Tang ZY;Xue Q;Shi DR,Song HY,Tang HB.Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor[J],2000(11).
  • 2Ono T;Yamanoi A;Nazmy El Assal O;Kohno H,Nagasue N.Adjuvantchemotherapy after resection of hepatocellular carcinoma causes deteriorationof long-term prognosis in cirrhotic patients: metaanalysis of threerandomized controlled trials,2001.
  • 3Yao FY;Ferrell L;Bass NM;Watson JJ,Bacchetti P,Venook A,AscherNL,Roberts JP.Liver transplantation for hepatocellular carcinoma:expansion of the tumor size limits does not adversely impact survival[J],2001.
  • 4Ouchi K;Sugawara T;Fujiya T;Kamiyama Y,Kakugawa Y,Mikuni J,Yamanami H,Nakagawa K.Prediction of recurrence and extratumor spreadof hepatocellular carcinoma following resection[J],2000.
  • 5Poon RT;Fan ST;Ng IO;Lo CM,Liu CL,Wong J.Different riskfactors and prognosis for early and late intrahepatic recurrence after resectionof hepatocellular carcinoma,2000.
  • 6Marsh JW;Dvorchik I;Bonham CA;Iwatsuki S.Is the pathologic TNMstaging system for patients with hepatoma predictive of outcome?[J],2000.
  • 7Yamanaka J;Ya naka N;Nakasho K;Tanaka T,Ando T,Yasui C,Kuroda N,Takata M,Maeda S,Matsushita K,Uematsu K,Ok amoto E.Clinicopathologic analysis of stage Ⅱ-m hepatocellular carcinoma showingearly massive recurrence after liver resection[J],2000(10).
  • 8Hino N;Higashi T;Nouso K;Nakatsukasa H,Urabe Y,Kinugasa N,Yoshida K,Ashida K,Ohguchi S,Tsuji T.Proliferating cell nuclearantigen and grade of malignancy in small hepatocellular carcinoma-evaluation in US-guided specimens,1997.
  • 9Wu PC;Fang JW;Lau VK.Classification ofhepatocellular carcinoma according to hepatocellular and biliarydifferentiation markers,1996.
  • 10Suehiro T;Matsumata T;Itasaka H;Yamamoto K,Kawahara N,Sugimachi K.Clinicopathologic features and prognosis of resectedhepatocellular carcinomas of varied sizes with special reference toproliferating cell nuclear antigen[J],1995.

共引文献12

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部